Microsoft Research unveils Quine, a biological world model for life sciences

The system is currently being tested in a joint study with the Broad Institute of MIT and Harvard, focusing on pancreatic ductal adenocarcinoma. In this workflow, Quine predicts which compounds might change cancer cell states, researchers test those candidates in the lab, and the results are fed back to refine future predictions. Microsoft reports that the computational screening of thousands of compounds was completed in one weekend, with experimental results confirming that highly ranked compounds caused the targeted changes more strongly than lower-ranked ones.

A notable finding was Quine’s prediction of a 'third state' in cell behavior, which was not part of the initial two-state hypothesis but was later confirmed by experiments. Microsoft emphasizes that Quine is an experimental research tool, not a clinical or medical device. The company notes that while it cannot fully simulate life, it aims to guide scientists toward the most promising experiments, marking a shift from AI that answers questions to AI that predicts real-world biological outcomes.